Therapy Areas: Central Nervous System
19 July 2019 - - US-based biopharmaceutical company Cortexyme, Inc. (NASDAQ: CRTX) has presented clinical data that supports its ongoing work to pioneer a novel, disease-modifying therapeutic approach...
19 July 2019 - PureTech Health, an advanced biopharmaceutical company developing novel medicines for dysfunctions of the Brain-Immune-Gut axis, has acquired and is planning to develop a clinical-stage...
18 July 2019 - - UK-based biopharmaceutical company PureTech Health plc (LSE: PRTC) has acquired and plans to develop a clinical-stage product candidate for the potential treatment of lymphatic and im...
12 July 2019 - - The United States Patent and Trademark Office (USPTO) has issued US Patent No. 10,344,091 to support biopharmaceutical company PureTech Health plc's (LSE: PRTC) internal immuno-o...
10 July 2019 - Bio-pharmaceutical company NeuroSearch A/S (CPH:NEUR) reported on Tuesday the receipt of a major shareholder announcement from Nordic Transport Group Holding A/S (NTG Holding) according...
2 July 2019 - - Italy-based biopharmaceutical company Newron Pharmaceutical S.p.A. (SIX: NWRN) has received Tranche 1 under its financing agreement with the European Investment Bank that was signed in...
Related Headlines